What the results might mean for the future of other developers in the cannabinoid receptor 1 (CB1) weight-loss arena came into question after Novo Nordisk A/S unveiled phase IIa findings with ...

Route 92 Medical Inc. sped past its series F goal, raising an additional $50 million in an extension to the oversubscribed round. The extension brings the total for the series F to $82 million, which ...

An innovation that has kickstarted a revolution in the study and practice of health care is getting even more attention.

Creo Medical Group plc entered into an agreement to sell a 51% stake in its European consumable business to Chinese medical ...

The draft Medicare physician fee schedule for calendar year 2025 provoked a strong backlash from physician societies due to a ...

In what represents its first patenting, Roseville, Minn.-based Iveacare Inc. provides insights as to what its first ...

As med-tech startups look to raise capital without diluting the valuation of their company, many may look to sell ...

Researchers from Johnson & Johnson presented the discovery of a novel inhibitor of cyclin-dependent kinase 7 (CDK7), a ...

The specter of elevated liver enzymes, a known problem with the drug class, became a topic of talk with regard to Sanofi SA’s ...

Australia is the skin cancer capital of the world, but with a shortage of dermatologists, patients often wait too long to get ...

Cincera Therapeutics Pty Ltd. and Monash University co-presented the phenotypic drug discovery of CIN-244, a novel MRTF/SRF ...

DNA is open and accessible, while the action of an epigenetic editor turns it into functionally inactive DNA, which is closed ...